MOPP (chemotherapy)

From WikiMD's Wellness Encyclopedia

MOPP (chemotherapy)

MOPP is an acronym for a chemotherapy regimen used in the treatment of Hodgkin's disease. The regimen was developed by researchers at the National Cancer Institute in the 1960s and was the first combination chemotherapy regimen to achieve a high cure rate in metastatic cancer.

History[edit | edit source]

The MOPP regimen was developed in the 1960s by researchers at the National Cancer Institute including Vincent T. DeVita Jr. and George Canellos. It was the first combination chemotherapy regimen to achieve a high cure rate in metastatic cancer.

Regimen[edit | edit source]

The MOPP regimen consists of four drugs:

The regimen is repeated every 3–4 weeks.

Side effects[edit | edit source]

The MOPP regimen has significant side effects including sterility, nausea, vomiting, hair loss, and an increased risk of secondary leukemia.

Alternatives[edit | edit source]

The MOPP regimen has largely been replaced by the ABVD regimen, which has fewer side effects and is equally effective. However, MOPP is still used in certain cases, such as when a patient cannot tolerate the drugs used in ABVD.

See also[edit | edit source]

References[edit | edit source]

MOPP (chemotherapy) Resources

Contributors: Prab R. Tumpati, MD